Summit Licenses GPCR Peptide Ligand Library to Merck

PharmaDesign (PDI) and its representative, Summit Pharmaceutical International (SPI), have announced that SPI has signed an agreement with Merck & Co. to license PharmaGPEP, a GPCR peptide ligand library designed and produced by PDI. Financial and other terms were not disclosed.
Yahoo News